DK0914419T3 - Transgene mus i stand til at udtrykke leukæmiinhiberende faktor - Google Patents

Transgene mus i stand til at udtrykke leukæmiinhiberende faktor

Info

Publication number
DK0914419T3
DK0914419T3 DK97921444T DK97921444T DK0914419T3 DK 0914419 T3 DK0914419 T3 DK 0914419T3 DK 97921444 T DK97921444 T DK 97921444T DK 97921444 T DK97921444 T DK 97921444T DK 0914419 T3 DK0914419 T3 DK 0914419T3
Authority
DK
Denmark
Prior art keywords
transgenic mice
pituitary
inhibitory factor
leukemia inhibitory
expressing leukemia
Prior art date
Application number
DK97921444T
Other languages
Danish (da)
English (en)
Inventor
Shlomo Melmed
Sadanori Akita
Carol Readhead
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Application granted granted Critical
Publication of DK0914419T3 publication Critical patent/DK0914419T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5415Leukaemia inhibitory factor [LIF]
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Eye Examination Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK97921444T 1996-05-09 1997-04-29 Transgene mus i stand til at udtrykke leukæmiinhiberende faktor DK0914419T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/647,401 US5824838A (en) 1996-05-09 1996-05-09 Transgenic mouse model for pituitary disorders associated with LIF overexpression and/or GH underexpression, and its use for testing therapeutic drugs for the conditions

Publications (1)

Publication Number Publication Date
DK0914419T3 true DK0914419T3 (da) 2004-09-06

Family

ID=24596845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97921444T DK0914419T3 (da) 1996-05-09 1997-04-29 Transgene mus i stand til at udtrykke leukæmiinhiberende faktor

Country Status (9)

Country Link
US (1) US5824838A (de)
EP (1) EP0914419B1 (de)
JP (1) JP2000509606A (de)
AT (1) ATE270328T1 (de)
DE (1) DE69729730T2 (de)
DK (1) DK0914419T3 (de)
ES (1) ES2219764T3 (de)
PT (1) PT914419E (de)
WO (1) WO1997042312A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP053197A0 (en) * 1997-11-26 1997-12-18 Amrad Operations Pty. Limited Compositions
AU744333B2 (en) * 1997-11-26 2002-02-21 Amrad Operations Pty. Limited Compositions of leukaemia inhibitory factor
AU753197B2 (en) 1998-07-06 2002-10-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Compositions and methods for in vitro fertilization
US6541244B1 (en) * 1999-06-07 2003-04-01 Cedars-Sinai Medical Center Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans
MXPA02004666A (es) 1999-11-12 2003-06-24 Fibrogen Inc Gelatinas recombinantes.
EP3224381B1 (de) 2014-11-25 2019-09-04 The Brigham and Women's Hospital, Inc. Verfahren zur identifizierung von personen mit einer prädisposition für eine kardiometabolische krankheit oder davon betroffenen personen
US10683552B2 (en) 2014-11-25 2020-06-16 Presidents And Fellows Of Harvard College Clonal haematopoiesis
WO2017053433A1 (en) 2015-09-21 2017-03-30 Modern Meadow, Inc. Fiber reinforced tissue composites
KR20170096094A (ko) 2016-02-15 2017-08-23 브렌던 패트릭 퍼셀 복합체 물질을 생제작하는 방법
CA3008850A1 (en) 2017-06-29 2018-12-29 Modern Meadow, Inc. Yeast strains and methods for producing collagen
AU2018253595A1 (en) 2017-11-13 2019-05-30 Modern Meadow, Inc. Biofabricated leather articles having zonal properties
US11352497B2 (en) 2019-01-17 2022-06-07 Modern Meadow, Inc. Layered collagen materials and methods of making the same
WO2020252282A1 (en) * 2019-06-14 2020-12-17 The Regents Of The University Of California Dna construct for targeting therapeutic molecules to diseased tissue by immune cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4736866B1 (en) * 1984-06-22 1988-04-12 Transgenic non-human mammals
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
EP0289121B1 (de) * 1987-05-01 1995-12-27 Stratagene Mutagenesetest durch Verwendung von nicht menschlichen Lebewesen, die Test-DNS-Sequenzen enthalten
US5175385A (en) * 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
US5175384A (en) * 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5215904A (en) * 1989-01-27 1993-06-01 Wisconsin Alumni Research Foundation Method for producing a recombinant mammal in vivo
US5175383A (en) * 1989-02-17 1992-12-29 President And Fellows Of Harvard College Animal model for benign prostatic disease
US5223610A (en) * 1990-05-18 1993-06-29 The Scripps Research Institute Cholera toxin gene regulated by growth hormone promoter

Also Published As

Publication number Publication date
ES2219764T3 (es) 2004-12-01
EP0914419A1 (de) 1999-05-12
EP0914419B1 (de) 2004-06-30
WO1997042312A1 (en) 1997-11-13
ATE270328T1 (de) 2004-07-15
PT914419E (pt) 2004-10-29
DE69729730D1 (de) 2004-08-05
JP2000509606A (ja) 2000-08-02
DE69729730T2 (de) 2005-07-07
US5824838A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
DK1049767T3 (da) En transgen kanin, der udtrykker et funktionelt humant lipoprotein(A)
DK0914419T3 (da) Transgene mus i stand til at udtrykke leukæmiinhiberende faktor
ES2187505T3 (es) Elementos cis de proteinas de cuerpo oleoso como señales reguladoras.
DE3765782D1 (de) Pyrazolin mit insektizidischer aktivitaet.
DE69427650D1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
HU9200548D0 (en) Improved activity process of recombined proteins
DE60133271D1 (de) Behandlung von knorpelerkrankungen
ATE540108T1 (de) Familie gh 61 polypeptiden
ATE360701T1 (de) Putrescin-n-methyltransferasepromotor
DE69328025T2 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DE3853446D1 (de) Fibronectinbindungsprotein und dessen Herstellung.
DE69033603D1 (de) Antagonisten von wachstumshormonen
DE69426121D1 (de) Gen grb3-3, variante und ihre verwendungen
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
DE69939586D1 (de) Inhibitoren für die gefässneubildung
DE59206628D1 (en) Expression signalpeptid-freier staphylokinasen
ATE148744T1 (de) Neue thrombininhibitorische proteine aus landblutegeln
DE60119347D1 (de) Verwendung von chimäres il6-il6r in huntingtonskrankheit
DE69838875D1 (de) Verwendung von mecamylamine zur behandlung von neuropsychiatrischen krankheiten die auf nicotin ansprechen
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE472603T1 (de) Atrsp gen promotoren
ITRA910008V0 (it) Distributopre semovente di mangime, pellettato di sfuso, per l'ali- mentazione di animali in batteria